文献速递妇科生殖医学

饮食干预对子宫内膜异位症女性疼痛和生活质量的影响:一项有对照组的前瞻性研究

The effect of dietary interventions on pain and quality of life in women diagnosed with endometriosis: a prospective study with control group.
PubMed 文献 · Hum Reprod · 2023-01-01

该前瞻性单中心先导研究于2021年4月至2022年12月纳入62例子宫内膜异位症女性,参与者可选择低FODMAP饮食、子宫内膜异位症饮食或不节食(对照组),随访6个月。与基线相比,节食组在6种疼痛症状中的4种报告疼痛减轻、11个生活质量域中的6个评分改善;与对照组相比,节食组腹胀显著减轻(P=0.049),11个生活质量域中有3个评分更优(P=0.002至P=0.035)。

要点

  • 与基线相比,节食组6种疼痛症状中4种减轻(P<0.001至P=0.012),11个生活质量域中6个改善(P<0.001至P=0.023)。
  • 与对照组相比,节食组腹胀显著减轻(P=0.049),11个生活质量域中3个评分更优(P=0.002至P=0.035)。
  • 本研究为先导研究,未计算样本量且未随机分组,可能产生选择偏倚,需进一步研究并制定指南。

核心结论

  • 本研究提示,坚持饮食干预6个月后子宫内膜异位症女性疼痛评分降低、生活质量改善,但鉴于这是先导研究、未计算样本量且缺乏长期(>6个月)数据,应谨慎解读。

研究设计与样本

  • 2021年4月至2022年12月开展的前瞻性单中心先导研究,纳入62例经手术和/或影像学诊断的子宫内膜异位症女性。
  • 参与者自行选择低FODMAP饮食(n=22)、子宫内膜异位症饮食(n=21)或不节食对照(n=19),随访6个月,节食组接受培训中营养师的广泛指导。

主要发现

  • 与基线相比,节食组在6种疼痛症状中的4种报告疼痛减轻(范围P<0.001至P=0.012),11个生活质量域中的6个评分改善(范围P<0.001至P=0.023)。
  • 与对照组纵向分析比较,节食组报告腹胀显著减轻(P=0.049),11个生活质量域中的3个评分更优(范围P=0.002至P=0.035)。

关键数值与推荐

  • 纳入标准为经手术和/或影像学诊断的子宫内膜异位症,且痛经、深部性交痛和/或慢性盆腔痛视觉模拟评分(0-10 cm)≥3 cm。
  • 主要终点为所有疼痛症状(包括排尿困难、腹胀和疲劳)的疼痛减轻,次要终点通过问卷评估生活质量、胃肠健康和饮食依从性。

临床怎么用

  • 作者认为女性可能从坚持饮食干预中获益,因为6个月后观察到更低的疼痛评分和更好的生活质量。
  • 作者指出应谨慎解读,因为这是先导研究、未计算样本量且缺乏长期(>6个月)效果数据。
  • 作者强调该先导研究结果凸显了进一步研究和制定指南的重要性。

局限性

  • 因文献缺乏疗效数据,未计算样本量。
  • 为优化饮食依从性未采用随机分组,可能导致选择偏倚。
  • 这是先导研究,未计算样本量,且缺乏长期(>6个月)效果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the influence of dietary interventions, namely the low fermentable oligo-, di-, mono-saccharides, and polyols (Low FODMAP) diet and endometriosis diet, on endometriosis-related pain and quality of life (QoL) compared to a control group? SUMMARY ANSWER: After adhering to a dietary intervention for 6 months, women with endometriosis reported less pain and an improved QoL compared to baseline whereas, compared to the control group, they reported less bloating and a better QoL in 3 of 11 domains. WHAT IS KNOWN ALREADY: Standard endometriosis treatment can be insufficient or may be accompanied by unacceptable side effects. This has resulted in an increasing interest in self-management strategies, including the appliance of the Low FODMAP diet and the endometriosis diet (an experience-based avoidance diet, developed by women with endometriosis). The Low FODMAP diet has previously been found effective in reducing endometriosis-related pain symptoms, whereas only limited studies are available on the efficacy of the endometriosis diet. A survey study recently found the endometriosis diet effective in improving QoL but currently no guidelines on use of the diet exist. STUDY DESIGN, SIZE, DURATION: A prospective one-center pilot study was performed between April 2021 and December 2022. Participants could choose between adherence to a diet-the Low FODMAP diet or endometriosis diet-or no diet (control group). Women adhering to a diet received extensive guidance from a dietician in training. The follow-up period was 6 months for all three groups. For all outcomes, women adhering to the diets were compared to their baseline situation and to the control group. PARTICIPANTS/MATERIALS, SETTING, METHODS: We included women diagnosed with endometriosis (surgically and/or by radiologic imaging) who reported pain scores ≥3 cm on the visual analogue score (0-10 cm) for dysmenorrhea, deep dyspareunia, and/or chronic pelvic pain. The primary endpoint focused on pain reduction for all pain symptoms, including dysuria, bloating, and tiredness. Secondary endpoints, assessed via questionnaires, focused on QoL, gastro-intestinal health, and diet adherence. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 62 participants were included in the low FODMAP diet (n = 22), endometriosis diet (n = 21), and control group (n = 19). Compared to their baseline pain scores, participants adhering to a diet reported less pain in four of six symptoms (range P < 0.001 to P = 0.012) and better scores in 6 of 11 QoL domains (range P < 0.001 to P = 0.023) after 6 months. Compared to the control group, analyzed longitudinally over the 6-month follow-up period, participants applying a diet reported significant less bloating (P = 0.049), and better scores in 3 of 11 QoL domains (range P = 0.002 to P = 0.035). LIMITATIONS, REASONS FOR CAUTION: No sample size was calculated since efficacy data were lacking in the literature. In order to optimize dietary adherence, randomization was not applied, possibly resulting in selection bias. WIDER IMPLICATIONS OF THE FINDINGS: Our study suggests that women could benefit from adherence to a dietary intervention, since we found lower pain scores and better QoL after 6 months. However, caution is implied since this is a pilot study, no sample size was calculated, and data on long-term effects (>6 months) are lacking. The results of this pilot study underline the importance of further research and the drawing up of guidelines. STUDY FUNDING/COMPETING INTEREST(S): A.v.H. reports receiving a travel grant from Merck outside the scope of this study. J.W., S.V., J.T., and B.D.B. have no conflicts of interest to report. A.d.V. reports having received KP-register points for internship guidance of J.W., performing paid consultations with endometriosis patients outside the study and receiving reimbursements for educational lectures at the local hospital (Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands). A.S. reports having received expenses for travel and hotel costs as an invited speaker from ESHRE. This was outside the scope of this study. M.v.W. reports that she is a Co-Ed of Cochrane Gynecology and Fertility. V.M. reports receiving travel and speaker's fees from Guerbet and research grants from Guerbet, Merck and Ferring. The department of reproductive medicine (V.M.) of the Amsterdam UMC, location VUmc, has received several research and educational grants from Guerbet, Merck and Ferring not related to the submitted work. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. van Haaps AP, Wijbers JV, Schreurs AMF, et al. The effect of dietary interventions on pain and quality of life in women diagnosed with endometriosis: a prospective study with control group. Hum Reprod. 2023. PMID: 37877417. doi:10.1093/humrep/dead214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。